N-(4-hydroxyphenyl)benzamide

ID: ALA229937

Cas Number: 15457-50-8

PubChem CID: 459327

Max Phase: Preclinical

Molecular Formula: C13H11NO2

Molecular Weight: 213.24

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Synonyms: N-(4-Hydroxyphenyl)Benzamide | N-(4-hydroxyphenyl)benzamide|15457-50-8|p-Benzamidophenol|Benzamide, N-(4-hydroxyphenyl)-|N-(4-Hydroxy-phenyl)-benzamide|4'-Hydroxybenzanilide|p-(N-Benzoylamino)phenol|N-(4-hydroxyphenyl)-benzamide|p-benzoylaminophenol|4-benzoylamino-phenol|N-benzoyl 4-hydroxyaniline|Oprea1_026787|Oprea1_270140|SCHEMBL679222|CHEMBL229937|DTXSID80165666|CVPWYDXAVJCNAG-UHFFFAOYSA-N|1-N-(4-Hydroxy-phenyl)-benzamide|MFCD00454145|AKOS000266826|AS-17960|CS-0307853|FT-0742194|EN300-08969|Show More

Canonical SMILES:  O=C(Nc1ccc(O)cc1)c1ccccc1

Standard InChI:  InChI=1S/C13H11NO2/c15-12-8-6-11(7-9-12)14-13(16)10-4-2-1-3-5-10/h1-9,15H,(H,14,16)

Standard InChI Key:  CVPWYDXAVJCNAG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -4.8092   -2.8002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8104   -3.6277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0975   -4.0405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3782   -3.6272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3814   -2.7962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0995   -2.3874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6689   -2.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9526   -2.7891    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2402   -2.3731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5278   -2.7848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840   -2.3694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1804   -1.5436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5412   -1.1349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2501   -1.5525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6731   -1.5553    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8921   -1.1266    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  7  8  1  0
  8  9  1  0
  4  5  1  0
  9 10  2  0
  2  3  1  0
 10 11  1  0
  5  6  2  0
 11 12  2  0
  6  1  1  0
 12 13  1  0
  1  2  2  0
 13 14  2  0
 14  9  1  0
  5  7  1  0
  7 15  2  0
  3  4  2  0
 12 16  1  0
M  END

Alternative Forms

Associated Targets(Human)

Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus ficuum (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus parasiticus (296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 213.24Molecular Weight (Monoisotopic): 213.0790AlogP: 2.64#Rotatable Bonds: 2
Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.44CX Basic pKa: CX LogP: 2.76CX LogD: 2.76
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.75Np Likeness Score: -0.86

References

1. Kumar A, Narasimhan B, Kumar D..  (2007)  Synthesis, antimicrobial, and QSAR studies of substituted benzamides.,  15  (12): [PMID:17428669] [10.1016/j.bmc.2007.03.074]
2. Hansen HC, Chiacchia FS, Patel R, Wong NC, Khlebnikov V, Jankowska R, Patel K, Reddy MM..  (2010)  Stilbene analogs as inducers of apolipoprotein-I transcription.,  45  (5): [PMID:20106565] [10.1016/j.ejmech.2009.12.076]

Source